UNIGE document Scientific Article
previous document  unige:94973  next document
add to browser collection

Bruceantin inhibits multiple myeloma cancer stem cell proliferation

Carpentier, Gilles
Pezzuto, John M
Published in Cancer biology and therapy. 2016, vol. 17, no. 9, p. 966-75
Abstract Multiple myeloma (MM) continues to claim the lives of a majority of patients. MM cancer stem cells (CSCs) have been demonstrated to sustain tumor growth. Due to their ability to self-renew and to express detoxifying enzymes and efflux transporters, MM-CSCs are rendered highly resistant to conventional therapies. Therefore, managing MM-CSCs characteristics could have profound clinical implications. Bruceantin (BCT) is a natural product previously demonstrated to inhibit the growth of MM in RPMI 8226 cells-inoculated mouse xenograft models, and to cause regression in already established tumors. The objectives of the present study were to test the inhibitory effects of BCT on MM-CSCs growth derived from a human primary tumor, and to explore a mechanism of action underlying these effects. BCT exhibited potent antiproliferative activity in MM-CSCs starting at 25 nM. BCT induced cell cycle arrest, cell death and apoptosis in MM-CSCs as well as inhibited cell migration and angiogenesis in vitro. Using a qPCR screen, it was found that the gene expression of a number of Notch pathway members was altered. Pretreatment of MM-CSCs with the γ-secretase inhibitor RO4929097, a Notch pathway inhibitor, reversed BCT-induced effects on MM-CSCs proliferation. In this study, BCT was shown to be an effective agent in controlling the proliferation, viability and migration of MM-CSCs as well as angiogenesis in vitro. The effect on MM-CSCs proliferation may be mediated by the Notch pathway. These results warrant further investigation of BCT in a broader set of human-derived MM-CSCs and with in vivo models representative of MM.
PMID: 27434731
Full text
Article (Published version) (1.4 MB) - document accessible for UNIGE members only Limited access to UNIGE
(ISO format)
ISSA, Mark Elia et al. Bruceantin inhibits multiple myeloma cancer stem cell proliferation. In: Cancer biology and therapy, 2016, vol. 17, n° 9, p. 966-75. https://archive-ouverte.unige.ch/unige:94973

82 hits

0 download


Deposited on : 2017-06-20

Export document
Format :
Citation style :